TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.91 / 10
Netural
Technical assessment is neutral with a 3.91/10 score. The Long Lower Shadow pattern signals bullish momentum (score 8.86), while Marubozu White and MACD Death Cross are bearish (scores 1 and 1.87). Overall market direction remains unclear.
Analysis Checks(1/3)
Long Lower Shadow
Score8.86/10
Win Rate69.05%
Hist. Signals42
Avg Return2.90%
Score8.86/10
Win Rate69.05%
Hist. Signals42
Avg Return2.90%
Marubozu White
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-1.58%
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-1.58%
MACD Death Cross
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.06%
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.06%
Long Lower Shadow
Score8.86/10
Win Rate69.05%
Hist. Signals42
Avg Return2.90%
Score8.86/10
Win Rate69.05%
Hist. Signals42
Avg Return2.90%
MACD Death Cross
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.06%
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.06%
Marubozu White
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-1.58%
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-1.58%
Technical Analysis of TRDA?
- TRDA presents a Netural setup with a Technical Score of 3.91/10. Key technical indicators highlight an RSI of 62.79 and a MACD of 0.09, with the trend anchored by the 50-Day SMA at 11.74. Traders should monitor key support at 12.20 and resistance at 12.95.
